A detailed history of Dauntless Investment Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Dauntless Investment Group, LLC holds 2,288 shares of CRL stock, worth $377,520. This represents 0.44% of its overall portfolio holdings.

Number of Shares
2,288
Holding current value
$377,520
% of portfolio
0.44%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$178.58 - $220.69 $408,591 - $504,938
2,288 New
2,288 $422 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.39B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Dauntless Investment Group, LLC Portfolio

Follow Dauntless Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dauntless Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dauntless Investment Group, LLC with notifications on news.